MacE v. Mylan Pharmaceuticals, Inc.

714 S.E.2d 223, 227 W. Va. 666
CourtWest Virginia Supreme Court
DecidedJuly 22, 2011
Docket35710
StatusPublished
Cited by34 cases

This text of 714 S.E.2d 223 (MacE v. Mylan Pharmaceuticals, Inc.) is published on Counsel Stack Legal Research, covering West Virginia Supreme Court primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
MacE v. Mylan Pharmaceuticals, Inc., 714 S.E.2d 223, 227 W. Va. 666 (W. Va. 2011).

Opinions

WORKMAN, Chief Justice:

The plaintiff below and appellant herein, Randy L. Mace (“Mr. Mace”), as personal representative of the Estate of Kathy W. Mace (“Ms. Mace”), appeals from an order of the Circuit Court of Monongalia County, West Virginia, dismissing his wrongful death lawsuit on the basis of forum non conveniens. Applying West Virginia Code § 56-1-la (Supp.2010), the foi'um non conveniens statute, the circuit court concluded that North Carolina, the state in which the action accrued, is a more convenient forum for Mr. Mace’s claims. Mr. Mace contends, however, that he is unable to try his claims in North Carolina, because they are barred by the statute of limitations in that state. Thus, he contends, the circuit court erred in dismissing the case, because it misinterpreted the forum non conveniens statute as permitting dismissal despite the lack of an alternate forum in which the claims may be tried.

Upon careful consideration, the Court finds that the language of the statute is ambiguous and should be construed in a manner that is consistent- with this Court’s prior case law and the federal common law doctrine of forum non conveniens. Under [669]*669this construction, the circuit court erred in its interpretation of the statute. Its order dismissing this action on the basis of forum non conveniens is, therefore, reversed and the case is remanded for further consideration consistent with this opinion.

I. FACTS AND PROCEDURAL HISTORY

Ms. Mace, a North Carolina resident, died on October 25, 2005, allegedly from an overdose of the narcotic pain medication, fentanyl. On July 1, 2008, Mr. Mace filed a wrongful death lawsuit in the Circuit Court of Monongalia County against Mylan Pharmaceuticals, Inc., Mylan, Inc., and Mylan Technologies, Inc. (jointly “the Mylan defendants”). Mylan Pharmaceuticals, Inc., is a West Virginia corporation with its headquarters in Morgantown, West Virginia; Mylan Technologies, Inc., is a West Virginia corporation with its headquarters in St. Albans, Vermont; and Mylan, Inc., is a Pennsylvania corporation with its headquarters in Canons-burg, Pennsylvania. Mr. Mace asserts that the Mylan defendants were responsible for the design, manufacture, marketing and distribution of a pain patch known as the Mylan Fentanyl Transdermal System (“the Mylan patch”).

In the complaint, Mr. Mace alleges that Ms. Mace was prescribed the Mylan patch on October 21, 2005, and that she died four days later from a fentanyl overdose while wearing that patch. Mr. Mace asserts claims of strict products liability, negligence, breach of implied warranty and breach of express warranty, and seeks punitive damages for deliberate, intentional reckless and/or malicious behavior.

Mr. Mace further asserts in the complaint that

[t]he plaintiff did not know, and a reasonable person under the circumstances would not have had reason to know, that the patches prescribed for, worn, and alleged to have been a cause of decedent’s death were manufactured by Mylan until less than two years before filing this complaint.

Importantly, both West Virginia and North Carolina, where Ms. Mace died, have a two-year statute of limitations for wrongful death claims. W. Va.Code § 55-7-6(d) (2008); N.C. Gen.Stat. § 1-53(4) (2008). In his brief to this Court, Mr. Mace explains that he had originally sued another generic drug manufacturer in California within two years of Ms. Mace’s death. During the course of that litigation, Mr. Mace discovered that the Mylan defendants were the actual manufacturers and distributors of the fentanyl patch worn by Ms. Mace. Accordingly, by the time Mr. Mace initiated this suit in West Virginia against the Mylan defendants, more than two years had passed after Ms. Mace’s death. If given the opportunity, Mr. Mace intends to argue that West Virginia’s discovery rule tolled the running of the statute of limitations in this case.

On July 22, 2008, the Mylan defendants filed a motion to dismiss based on the doctrine of forum non conveniens, which is codified in West Virginia Code § 56-1-la. They argued that North Carolina is the appropriate forum in which to litigate the case because Ms. Mace was a resident of North Carolina, she was prescribed and used the Mylan patch in North Carolina, and she died in North Carolina. The Mylan defendants further asserted that the Mylan patch was manufactured at a production facility in St. Albans, Vermont, and was shipped from Vermont to North Carolina. Accordingly, the Mylan defendants argued that the cause of action arose in North Carolina and the suit’s only connection to West Virginia is that two of the Mylan defendants are incorporated under West Virginia law, and one has its corporate headquarters in the state. Thus, the Mylan defendants argued that North Carolina is a more convenient forum.

Mr. Mace opposed the Mylan defendants’ motion, arguing that none of the Mylan defendants’ employees reside in North Carolina and that he would make the relevant North Carolina fact witnesses available to the Mylan defendants in West Virginia for depositions. Mr. Mace further asserted that, although North Carolina and West Virginia both have two-year statutes of limitations for wrongful death claims, only West Virginia permits tolling the statute of limitations based on the discovery rule. Accordingly, Mr. Mace asserted that he would not be able [670]*670to pursue the wrongful death claim in North Carolina unless the Mylan defendants waived their statute of limitations defense in that state. He argued that, without such a waiver, North Carolina is not available as an alternate forum in which the claims could be tried.

On December 16, 2008, the circuit court entered an order dismissing the case on the basis of forum non conveniens. Among other things, the circuit court concluded that “the Plaintiff resides in North Carolina and the decedent was a resident of North Carolina. The Mylan patch was used by the decedent[ ] while [she was] living in ... North Carolina. Therefore, an alternate forum exists in which to bring [this] action[].” The circuit court further noted, however, that

[t]he Defendants submit that they will consent to and will not contest personal jurisdiction in ... North Carolina. This is especially important ... as North Carolina does not recognize the discovery rule in wrongful death actions and the case is already barred under the two-year statute of limitations.

Accordingly, the circuit court dismissed the action on the basis of forum non conveniens, with the caveat that the Mylan defendants would consent to personal jurisdiction in North Carolina and waive their statute of limitations defense in that state.

On February 17, 2009, the Mylan defendants filed a motion to amend and/or clarify the circuit court’s order arguing that, while they had agreed to waive any new statute of limitations defense, they should not be “required to waive any statute of limitations defense that existed at the time of the commencement of the West Virginia litigation____” The Mylan defendants asserted that the circuit court’s order did not accurately reflect the discussion which had occurred at the oral argument on them motion. In response, on February 19, 2009, Mr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

State of West Virginia v. Kevin Woodrum
West Virginia Supreme Court, 2020
M.M., a Minor, By and Through Her Mother, etc. v. Pfizer, Inc.
806 S.E.2d 800 (West Virginia Supreme Court, 2017)
SER Betty J. Almond v. Hon. Rudolph Murensky, Judge, and Pfizer, Inc.
794 S.E.2d 10 (West Virginia Supreme Court, 2016)
Espinoza v. Evergreen Helicopters, Inc.
376 P.3d 960 (Oregon Supreme Court, 2016)
SER Rajai T. Khoury, M.D. v. Hon. Jason A. Cuomo, Judge
783 S.E.2d 849 (West Virginia Supreme Court, 2016)
SER American Electric Power v. Hon. David W. Nibert, Judge
784 S.E.2d 713 (West Virginia Supreme Court, 2016)
Patricia S. Reed, Commissioner WV DMV v. Robin J. Riner
778 S.E.2d 568 (West Virginia Supreme Court, 2015)
SER J.C., a minor v. Hon. James P. Mazzone, Judge
772 S.E.2d 336 (West Virginia Supreme Court, 2015)
SER Ford Motor Co. v. Hon. David W. Nibert, Judge
773 S.E.2d 1 (West Virginia Supreme Court, 2015)
Steven O. Dale, Acting Commissioner, W. Va. DMV v. Christina Painter
765 S.E.2d 232 (West Virginia Supreme Court, 2014)
State v. George K.
760 S.E.2d 512 (West Virginia Supreme Court, 2014)
Roger F. Holt v. West Virginia American Water Co.
West Virginia Supreme Court, 2014
Holt v. West Virginia-American Water Co.
760 S.E.2d 502 (West Virginia Supreme Court, 2014)
SER North River Insurance v. Hon. Robert F. Chafin, Special Judge
758 S.E.2d 109 (West Virginia Supreme Court, 2014)
Joseph Kubican v. The Tavern, LLC, d/b/a Bubba's Bar and Grill
752 S.E.2d 299 (West Virginia Supreme Court, 2013)
Judith Collett, Assessor v. Eastern Royalty, LLC
751 S.E.2d 12 (West Virginia Supreme Court, 2013)

Cite This Page — Counsel Stack

Bluebook (online)
714 S.E.2d 223, 227 W. Va. 666, Counsel Stack Legal Research, https://law.counselstack.com/opinion/mace-v-mylan-pharmaceuticals-inc-wva-2011.